Article ID Journal Published Year Pages File Type
8786701 European Journal of Surgical Oncology (EJSO) 2018 21 Pages PDF
Abstract
The morbidity of rectosigmoid resection during cytoreductive surgery for ovarian cancer seems acceptable. Ileostomy does not seem associated with a lower risk of major complications or adjuvant bevacizumab with a higher complication rate.
Related Topics
Health Sciences Medicine and Dentistry Oncology
Authors
, , , , , , , , , ,